| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +94.7K | 100% | $0.68 | +$64.9K |
| Sells | 0 | ||||
| Net | +2 | +94.7K | 100% | +$64.9K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jin Long Chen | Chief Scientific Officer, Director | $1.3M | Mar 2, 2023 | ||
| Mangini Siobhan Nolan | President and CFO | $102K | Mar 2, 2023 | ||
| Column Group Gp, Lp | 10%+ Owner | $1.34K | Apr 5, 2024 | ||
| TCG Opportunity III GP, LLC | 10%+ Owner | $1.34K | Apr 5, 2024 | ||
| Column Group L P | Director, 10%+ Owner | $1.34K | +$46.5K | Apr 5, 2024 | |
| David V. Goeddel | Director, 10%+ Owner | $1.34K | +$18.3K | Apr 5, 2024 | |
| David J. Woodhouse | Chief Executive Officer, Director | $0 | Apr 5, 2024 | ||
| William Jl Rieflin | Director | $0 | Apr 5, 2024 | ||
| Jean-Frederic Viret | Chief Financial Officer | $0 | Mar 26, 2024 | ||
| Suzanne Sawochka Hooper | Director | $0 | Apr 5, 2024 | ||
| Hsiao D. Lieu | Chief Medical Officer | $0 | Apr 5, 2024 | ||
| Irene Perlich | Principal Accounting Officer | $0 | Apr 5, 2024 | ||
| Valerie Pierce | General Counsel, Chief Compliance Officer and Secretary | $0 | Mar 26, 2024 | ||
| Roger M. Perlmutter | Director | Apr 5, 2024 | |||
| Shelly D. Guyer | Director | Apr 5, 2024 | |||
| Carole Ho | Director | Apr 5, 2024 | |||
| Mark Leschly | Director | Jun 8, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|